<?xml version="1.0" encoding="UTF-8" ?>
<ClinicalNarrativeTemporalAnnotation>
<TEXT><![CDATA[
ADMISSION DATE :
09/21/92
DISCHARGE DATE :
09/24/92
DISCHARGE DATE :
09/24/92
HISTORY OF PRESENT ILLNESS :
The patient is a seventy-one year old white female with stenotic area on her mid sigmoid , noticed on barium enema .
The ultrasound showed ascites and question of pelvic mass .
The patient was explored by General surgery , who saw the 3C ovarian carcinoma .
The patient also had an omentectomy and ileostomy .
The patient was admitted for one cycle of Cytoxan and Cisplatin , and subsequently underwent debulking in June 1992 , as well as a total abdominal hysterectomy/ bilateral salpingo-oophorectomy , omentectomy , splenectomy , rectosigmoid resection with a take down of the ileostomy .
Also ileal cecal resection , MDR showed that Cisplatin and VP 16 were more effective .
The patient now presents for line 1 , cycle 4 to 15 of VP 16 and Cisplatin chemotherapy .
HOSPITAL COURSE :
The patient was admitted to the hospital and received two units of packed red blood cells for her hematocrit of 26 , and had a magnesium repleted .
The patient received three days of chemotherapy , consisting of 45 mg. of Cisplatin 160 mg. of VP 16 , and tolerated chemotherapy resonably well .
Serial PTs were obtained , and the patient was noted to have an initial PT of 10.9 on admission , despite Coumadin at home .
She was given 10 mg. on hospital day # 1 , and 5 mg. on hospital day 2 , and back to 2.5 qhs .
The patient &apos;s pro time bumped to 19.5 on hospital day # 3 , and the patient was instructed to continue with 2 1/2 mg. qhs and is to followup with Anticoagulation Clinic in one week for further pro time checks and adjustments .
The patient did develop some hypertension during infusion of her VP 16 to the 170/100 range , which apparently happened during her prior chemotherapy .
The patient was instructed to followup with her internist regarding further evaluation of her hypertension , and should be assessed regarding further management , as an inpatient , or while receiving chemotherapy .
]]></TEXT>
<TAGS>
</TAGS>
</ClinicalNarrativeTemporalAnnotation>